"We are delighted that Wyeth has joined the group of prestigious companies turning to our PKS Suite software products," said Shawn O'Connor, president and chief executive officer of Pharsight. "We are committed to developing intelligent software technologies for automating data management and analysis procedures, and our agreement with Wyeth demonstrates an adoption of the solutions that can significantly advance drug development. The Pharsight Knowledgebase Server will allow Wyeth to fully integrate its pharmaceutical information technology systems, offering direct data access, rapid analysis, and quick, accurate reporting throughout the drug development process." Under the terms of the agreement, Pharsight will work closely with Wyeth to implement the Pharsight(R) Knowledgebase Server(TM) (PKS), PKS Reporter(TM) and PK Automation Services into its drug development process at Wyeth's Collegeville, PA, and Pearl River, NY locations. Pharsight's entire PKS Suite offers pharmaceutical companies high-performance, reliable tools for PK/PD analysis and a methodology that helps maximize resources and speed decision-making during the drug development process. PKS is designed to enable pharmaceutical and biopharmaceutical companies to better manage and help control pharmacokinetic data in compliance with the U.S. Food and Drug Administration's (FDA) regulation, 21 CFR Part 11, which has set new standards for computer system validation and usage. In addition, PK Automation Services assist clients in developing automation tools to dramatically reduce the work effort and cycle times associated with routine PK/PD analysis.